Abstract
Angiosarcomas are a rare subtype of soft-tissue sarcomas which exhibit aggressive clinical phenotypes with limited treatment options and poor outcomes. In this study, we investigated the clinical relevance of the peripheral blood neutrophil-to-lymphocyte ratio (NLR) as a marker of systemic immune response, as well as its correlation with intra-tumoral immune profiles in a subgroup of cases (n = 35) using the NanoString PanCancer IO360 panel and multiplex immunohistochemistry. In the overall cohort (n = 150), angiosarcomas of the head and neck (AS-HN) comprised most cases (58.7%) and median overall survival (OS) was 1.1 year. NLR, classified as high in 78 of 112 (70%) evaluable patients, was independently correlated with worse OS (HR 1.84, 95%CI 1.18–2.87, p = 0.0073). Peripheral blood NLR was positively correlated with intra-tumoral NLR (tNLR) (Spearman’s rho 0.450, p = 0.0067). Visualization of tumor-infiltrating immune cells confirmed that tNLR scores correlated directly with both neutrophil (CD15+ cells, rho 0.398, p = 0.0198) and macrophage (CD68+ cells, rho 0.515, p = 0.0018) cell counts. Interestingly, tNLR correlated positively with oncogenic pathway scores including angiogenesis, matrix remodeling and metastasis, and cytokine and chemokine signaling, as well as myeloid compartment scores (all p < 0.001). In patients with documented response assessment to first-line chemotherapy, these pathway scores were all significantly higher in non-responders (47%) compared to responders. In conclusion, systemic and local immune responses may inform chemotherapy response and clinical outcomes in angiosarcomas.
Highlights
Angiosarcomas represent a rare subtype of soft-tissue sarcomas and are aggressive malignant mesenchymal tumors of endothelial cell origin
Eighteen patients (12.0%) had reported specific risk factors for angiosarcoma, including prior irradiation at the site of tumor origin (n = 8), chronic lymphedema (n = 3), and disease originating from a thrombosed arteriovenous fistula (n = 3)
Our results demonstrate several unique features of angiosarcomas within this cohort of Asian patients
Summary
Angiosarcomas represent a rare subtype of soft-tissue sarcomas and are aggressive malignant mesenchymal tumors of endothelial cell origin. In terms of clinical presentation and behavior, these tumors often exhibit significant heterogeneity, and can develop in various anatomical structures, including the head and neck region, breast, viscera, trunk, and extremities[1,2]. Notwithstanding their rarity, several predisposing risk factors have been previously described. Angiosarcomas of the head and neck (AS-HN) have been shown to be more prevalent in Asian populations, as compared with Western patients, raising the possibility of unique genetic or environmental factors influencing its pathogenesis[5]. In a large patient-partnered US-Canadian research initiative (The Angiosarcoma Project)6, 80%
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
